Evidence map›Paper›PMID 41021651›Full record

ArticlePloS one2025

Does financial compensation matter for research participation in prevention trials in Tanzania? Perspectives of healthy volunteers.

Raymond Athanas, Heavenlight A Paulo, Gasto Frumence, Masunga K Iseselo, Connie M Ulrich

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raymond AthanasDepartment of Bioethics and Health Professionalism, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.ORCID 0000-0002-4655-2279
Heavenlight A PauloDepartment of Epidemiology and Biostatistics, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.ORCID 0000-0002-3162-9982
Gasto FrumenceDepartment of Development Studies, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Masunga K IseseloDepartment of Clinical Nursing, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.ORCID 0000-0001-5881-4435
Connie M UlrichBiobehavioral Department, School of Nursing, NewCourtland Center for Transitions and Health, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFinancial compensation is an important aspect of respect for people enrolled in clinical research, yet continues to raise ethical questions. Respondents' characteristics, shaped by contextual and geographic factors, may influence perceptions of the ethical implications of financial compensation. This study explored the relationship between respondents' characteristics and their ethical perspective on the role of financial compensation in prevention trials in Tanzania. MATERIALS AND

methodsA cross-sectional survey of 537 participants from two prevention studies within Tanzania was conducted. Participants were eligible if they participated in either the HIV Pre-Exposure Prophylaxis Vaccine Trial (PrEPVacc) trial or a non-inferiority trial of low-dose compared to standard high-dose calcium supplementation in pregnancy in Tanzania. A questionnaire was used to collect participants' sociodemographic characteristics and motivating reasons for research participation. Data analysis was performed using descriptive statistics for all variables. The chi-square test was used to assess associations between categorical demographic characteristics and binary outcomes scores. Modified Poisson regression models were employed to examine predictors of positive or negative perspectives for each outcome. The P value of < 0.05 was used to ascertain the significant association between the variables.

resultsMost participants (82.5%) were young adults between the ages of 18-28 years, married or cohabiting (60.7%), and self-employed (55.9%). All participants in the cohort were female. Key motivations for research participation included medical follow-up (96.8%), quality information (94.4%), and disease control (92.2%). The majority also reported feeling a duty to participate (90.5%) with 50.1% indicating that they felt an obligation to the person who requested their participation. More than a third (36.9%) wanted to receive an incentive and reimbursement (38.7%) for out-of-pocket expenses. Financial compensation was a less common motivator among married or cohabiting participants compared to single individuals (APR = 0.54, 95% CI: 0.42-0.71, p < 0.001). Participants with primary education were also less likely to report financial compensation motivations compared to those with no formal education (APR = 0.57, 95% CI: 0.41-0.78, p < 0.001). Also, participants who had taken part in two or more trials had significantly higher non-financial participation motivations compared to those with only one research experience (p < 0.001).

conclusionFinancial compensation matters to certain participant subgroups, but its role varies. While some value monetary benefits, others prioritize altruism and trust in research oversight. A balanced, transparent compensation framework is needed to address financial needs while maintaining ethical integrity.

Indexed as

Compensation and RedressHealthy VolunteersHIV InfectionsAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedMotivationSurveys and QuestionnairesTanzaniaYoung Adult

Identifiers

PMID41021651
PMCPMC12478931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.